Betrixaban: a direct oral inhibitor of activated factor X for the prophylaxis of venous thromboembolism in patients hospitalized for acute medical illness. Drugs Today (Barc) • November 10, 2017
Future trends in the treatment of serious Gram-positive infections. Drugs Today (Barc) • June 12, 2009
Oral formulations of budesonide: a novel treatment for inflammatory bowel disease. Drugs Today (Barc) • April 22, 2009
Diastolic dysfunction: a link between hypertension and heart failure. Drugs Today (Barc) • October 22, 2008
Retapamulin: a new topical antibiotic for the treatment of uncomplicated skin infections. Drugs Today (Barc) • July 24, 2008